Thalassemia major - On the verge of bleeding or thrombosis?

Hematology

Volumn 11, Issue 1, 2006, Pages 57-61

  Naithani, Rahul ^a,c   Chandra, Jagdish ^a   Narayan, Shashi ^b   Sharma, Sunita ^b   Singh, Varinder ^a  

^a KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Bleeding; Children; Hemostatic derangements; Thalassemia major; Trombosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; D DIMER; DEFERIPRONE; DEFEROXAMINE; FERRITIN; FIBRINOGEN; IRON; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BETA THALASSEMIA; BLEEDING; BLEEDING TENDENCY; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; IRON BLOOD LEVEL; IRON CHELATION; LIVER FUNCTION TEST; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; THALASSEMIA MAJOR; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

ADOLESCENT; AGE FACTORS; BETA-THALASSEMIA; BLOOD COAGULATION; BLOOD PROTEINS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; HEMORRHAGE; HUMANS; MALE; PROTHROMBIN TIME; RISK FACTORS; THROMBOSIS;

EID: 33644828481     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500362087     Document Type: Article

References (22)

1. Ibrahim, CP. (1999) Haemostatic derangements and lupus anticoagulant in polytransfused patients of beta-thalassaemia major Asian J Paed Pract, 3(2).
2. Hilgartner, MW and Erlandson, ME and Smith, CH. (1981) The coagulation mechanism in patients with thalassaemia major J Pediatr, 99, pp. 700 - 703.
3. Eldor, A. (1978) Hemorrhagic tendency in beta-thalassaemia major Isr J Med Sci, 14, pp. 1132 - 1134.
4. Rai, R and Pati, H and Arya, LS and Saraya, AK. (1987) Platelet aggregation in homozygous beta thalassaemia Ind J Med Res, 86, pp. 61 - 64.
5. Logothetis, J and Constantoulakis, M and Econ omiclou, J and (1972) Thalassaemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects Neurology, 22, pp. 294 - 304.
6. Pignatti, BC and Carnelli, V and Caruso, V and Dore, E and De Mattia, D and Di Palma, A. (19981999) Thromboembolic events in beta thalassaemia major - An Italian multicenter study Acta Haematol, pp. 76 - 79.
7. Cappellini, MD and Robbiolo, L and Bottasso, BM and Coppola, R and Fiorelli, G and Mannucci, AP. (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia Br J Haematol, 111, pp. 467 - 473.
8. Sinniah, D and Vigenendra, V and Ahmad, K. (1977) Neurological complications of thalassemia major Arch Dis Child, 52, pp. 977 - 979.
9. Michaeli, J and Mittelman, M and Gisaru, D and Rachmilewitz, EA. (1992) Thromboembolic complications in beta thalassaemia major Acta Haematol, 87, pp. 71 - 74.
10. Eldor, A and Durst, R and Hy-Am, E and (1999) A chronic hypercoagulable state in patients with beta-thalassemia major is already present in childhood Br J Haematol, 107, pp. 739 - 746.
11. Sonakul, D and Pacharee, P and Lohapand, T and Fucharoen, S and Wasi, P. (1980) Pulmonary artery obstruction in thalassemia Southeast Asian J Trop Med Public Health, 11, pp. 516 - 523.
12. Friedlander, ZG and Rund, D. (2004) Myocardial infarction in a patient with β-thalassemia major: First report Am J Hematol, 75, pp. 52 - 55.
13. Mussumeci S Leonardo S Dio R.D.Fischer A.Cosia G.D. 1987 Protein C and Antithrombin III in polytransfused thalassemia patients Acta haematol 77 30-33
14. Shirahata, A and Funahara, Y and Opartkiattikul, N and Fucharoen, S and Laosombat, V and Yamada, K. (1992) Protein C and protein S deficiency in thalassemic patients Southeast Asian J Trop Med Public Health, 23, pp. 65 - 73.
15. Choudhary, VP and Kotwal, J and Saxena, R. (1998) Thalassemia screening and control programme Paediatr Today, 1(3), pp. 283 - 286.
16. Lewis, SM and Bain, BJ and Bates, I.(2001) Practical haematology 9th ed. London: Churchill Livingstone.
17. Caocci, L and Alberti, M and Burrai, P and Corda, R. (1978) Sereening coagulation tests and clotting factors in homozygous beta thalassaemia Acta Haematol, 60, pp. 358 - 364.
18. Rabiner, SF and Rosefeld, S. (1963) Role of intravascular hemolysis and the reticuloendothelial system in the production of hypercoagulable state J Lab Clin Med, 63, pp. 1005 - 1009.
19. Andrew, M and Manno, M and Kapatkin, M. (1983) Demonstration of Kallikrein-like protease activity in nonactivated plasma of patients with Cooley's anemia Blood, 61, pp. 232 - 237.
20. Cappellini, MD and Coppola, R and Bottasso, B and Grazlader, G and Fargion, S and Manucci, PM and (1995) Hypercoagulability in patients with thalassaemia intermedia Blood, 77, pp. 30 - 33.
21. Eldor, A and Rachmilewitz, EA. (2002) The hypercoagulable state in thalassemia Blood, 99, pp. 36 - 43.
22. Moratelli, S and De Sanctis, V and Gemmati, D and (1998) Thrombotic risk in thalassemic patients J Pediatr Endocrinol Metab, 11, pp. 915 - 921.